Click on the Manage Content for adding and managing content.
Click on the Rotator Settings and choose what and how it will be displayed.

Ads are coming to ChatGPT conversations

Kraig Pakulski 0 33 Article rating: No rating

By Clare Duffy, CNN

New York (CNN) — ChatGPT may soon serve up ads for products it thinks you’d like to buy.

OpenAI announced on Friday that it will be testing ads in its free version for logged-in, adult US users. It’s also rolling out an $8-per-month “Go” subscription tier that includes some upgraded capabilities, such as longer memory and more image creation opportunities, a lower price than its “Plus” ($20/month) and Pro ($200/month) subscriptions. “Go” subscribers will also get ads, while Plus, Pro and OpenAI’s business customers won’t.

OpenAI CEO Sam Altman has previously expressed reservations about introducing ads to ChatGPT. But the move comes as OpenAI is urgently trying to figure out how to bring in more revenue to help it afford the $1.4 trillion it has committed to spending on AI infrastructure over the next eight years. Altman said in November that the company expected to end 2025 with around $20 billion in annual revenue.

Last year, the company launched a tool called “Instant Checkout” that lets users buy items from retailers such as Walmart and Etsy directly through ChatGPT. OpenAI also introduced health and learning tools, among others, as it looks to make ChatGPT a more essential part of users’ everyday lives and potentially give them a reason to upgrade to a paid subscription.

Advertising could prove a lucrative strategy for OpenAI, as using the information from people’s conversations with ChatGPT could make for highly targeted ads. For example, if a user asked ChatGPT for help planning a trip, it could serve up ads for a hotel or entertainment in the area.

As part of the test, ads will show up at the bottom of ChatGPT’s answer to a user’s query and will be labeled as “sponsored.” OpenAI said ads won’t dictate the answers ChatGPT provides, adding that users “need to trust that ChatGPT’s responses are driven by what’s objectively useful.”

The company also said it will not sell user data or conversations to advertisers and that users can turn off ad personalization based on their chats. OpenAI doesn’t plan to advertise in conversations about “regulated topics” including health, mental health or politics.

“Given what AI can do, we’re excited to develop new experiences over time that people find more helpful and relevant than any other ads,” OpenAI said in a blog post. “Soon you might see an ad and be able to directly ask the questions you need to make a purchase decision.”

Altman said in a 2024 interview that he “hates” ads and called the idea of combining ads with AI “uniquely unsettling,” although he added that “I’m not saying OpenAI would never consider ads.” Last year, he said he wasn’t “totally against” adding ads to ChatGPT, but said it would “take a lot of care to get right.”

Inserting ads into chatbot conversations could be controversial, given users’ sometimes personal and intimate conversations. And the move will amp up the pressure on OpenAI to ensure it doesn’t recommend products that could be potentially dangerous or harmful, especially after the company has faced lawsuits alleging that ChatGPT encouraged users’ suicides.

OpenAI said it will not serve ads to users who have identified themselves as, or who it believes are, under 18. (The company uses AI to estimate users’ ages based on their conver

Supreme Court agrees to hear longstanding fight over Roundup cancer claims

Kraig Pakulski 0 31 Article rating: No rating

By John Fritze, Sarah Owermohle, CNN

(CNN) — The Supreme Court said Friday that it will decide whether tens of thousands of people claiming the pesticide Roundup caused their cancer will have a day in court, or whether a federal law that regulates pesticide labeling will effectively block their cases from moving forward.

The court’s decision to hear the case has significant practical implications for agriculture – which heavily relies on the product – and Americans who claim Monsanto violated various laws by failing to warn them about the risk of cancer. It also raises an interesting political issue for the Trump administration, which is backing Monsanto even though HHS Secretary Robert F. Kennedy Jr. has long criticized the product.

The court will likely hear arguments in the spring.

Monsanto was purchased by German-based Bayer in 2018.

The Supreme Court appeal followed a $1.25 million jury verdict in favor of John Durnell, who sued Monsanto in Missouri state court in 2019, alleging that he developed non-Hodgkin’s lymphoma after being exposed to Roundup. A state appeals court upheld that decision.

Monsanto, which has faced more than 100,000 similar claims across the country, has argued that a federal law enacted in the 1970s that gives the Environmental Protection Agency power to regulate pesticides preempts state law claims like Durnell’s. That argument, if embraced by the Supreme Court, would likely foreclose many of the pending suits against the company.

The company has already removed the active ingredient in Roundup, glyphosate, from the consumer version of its product. But glyphosate remains the central ingredient in industrial versions widely used by farmers.

The EPA under both Democratic and Republican administration has repeatedly concluded that glyphosate does not cause cancer and has declined to require cancer warnings on Roundup’s labeling. But in 2015, the International Agency for Research on Cancer classified glyphosate as an agent that is “probably carcinogenic to humans.” Several juries have sided with plaintiffs who sought damages after claiming they were diagnosed with non-Hodgkin’s lymphoma because of their exposure to the product.

As the case was pending at the Supreme Court, a scientific journal retracted a landmark study it published 25 years ago concluding that glyphosate is safe. Emails uncovered as part of other litigation against the company demonstrated Monsanto employees were heavily involved in that study, a situation the journal said raised “serious ethical concerns regarding the independence and accountability” of its authors.

“EPA has repeatedly determined that glyphosate, the world’s most widely used herbicide, does not cause cancer,” Monsanto’s attorney told the Supreme Court in an appeal filed in April. “EPA has consistently reached that conclusion after studying the extensive body of science on glyphosate for over five decades.”

Durnell said he sprayed the weedkiller in parks near his home for years.

“The result was a deadly and incurable form of non-Hodgkin lymphoma, a blood cancer,” his attorneys told the Supreme Court. “The jury found that Roundup caused that cancer and that Monsanto was liable for Durnell’s damages.”

Monsanto claims that the Federal Insecticide, Fungicide, and Rodenticide Act preempts state labeling requirements. But Durnell has countered that he relied on off-label advertisements from the company, which he said marketed the product as safe to spray without the use of protective equipmen

RSS
First37283729373037313733373537363737Last